Joris Wilms
Profile
Joris Wiel Jan Wilms formerly worked at Genmab A, as Associate Director-Clinical Development from 2008 to 2010, KLIFO A, as Vice President-Clinical Trial Services from 2010 to 2016, and Y-mAbs Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2017 to 2025.
Mr. Wilms received his graduate degree from the University of Groningen.
Former positions of Joris Wilms
| Companies | Position | End |
|---|---|---|
| YMAS THER | Chief Operating Officer | 16/09/2025 |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | 01/01/2016 |
| GENMAB A/S | Corporate Officer/Principal | 01/12/2010 |
Training of Joris Wilms
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genmab A/S
Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. Develops novel antibody therapeutics for oncology targets |
- Stock Market
- Insiders
- Joris Wilms
















